Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report

BACKGROUND: After acute infection of Epstein-Barr virus, Epstein-Barr virus-infected B cells survive but usually do not show clonal proliferation. However, Epstein-Barr virus-infected B cells occasionally acquire a proliferative capacity that provokes clonal lymphoproliferative disorders. We herein...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Case Rep
Päätekijät: Ueda, Koki, Ikeda, Kazuhiko, Ogawa, Kazuei, Sukegawa, Masumi, Sano, Takahiro, Kimura, Satoshi, Suzuki, Osamu, Hashimoto, Yuko, Takeishi, Yasuchika
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997747/
https://ncbi.nlm.nih.gov/pubmed/27557810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-1009-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia